Reducing the impact of viral respiratory infections in children

被引：16

作者：

Meissner, HC ^{[1
]}

机构：

[1] Tufts Univ, Sch Med, Div Pediat Infect Dis, Tufts New England Med Ctr, Boston, MA 02111 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2005年 / 52卷 / 03期

关键词：

D O I：

10.1016/j.pcl.2005.02.010

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

This article reviews the epidemiology and clinical aspects of the major viral causes of upper and lower respiratory tract disease in children. Particular emphasis is placed on prevention and control of viral disease through the use of vaccines and antiviral agents. Evolution of new viral pathogens, such as avian influenza virus and the SARS-CoV, are discussed.

引用

页码：695 / +

页数：17

共 49 条

[1] Revised indications for the use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the prevention of respiratory syncytial virus infections [J].

Abramson, JS ;

Baker, CJ ;

Baltimore, RS ;

Bocchini, JA ;

Long, SS ;

McMillan, JA ;

Meissner, HC ;

Powell, KR ;

Prober, CG ;

Rennels, MB ;

Saari, TN ;

Weiner, LB ;

Blackmon, L ;

Batton, DG ;

Bell, EF ;

Denson, SE ;

Engle, WA ;

Kanto, WP ;

Martin, GI ;

Stark, AR .

PEDIATRICS, 2003, 112 (06) :1447-1452

[2]

Abramson JS, 2003, PEDIATRICS, V112, P1442

[3]

[Anonymous], 1999, MMWR Recomm Rep, V48, P1

[4] Frequency and natural history of rhinovirus infections in adults during autumn [J].

Arruda, E ;

Pitkaranta, A ;

Witek, TJ ;

Doyle, CA ;

Hayden, FG .

JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (11) :2864-2868

[5] Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children [J].

Belshe, RB ;

Newman, FK ;

Anderson, EL ;

Wright, PF ;

Karron, RA ;

Tollefson, S ;

Henderson, FW ;

Meissner, HC ;

Madhi, S ;

Roberton, D ;

Marshall, H ;

Loh, R ;

Sly, P ;

Murphy, B ;

Tatem, JM ;

Randolph, V ;

Hackell, J ;

Gruber, W ;

Tsai, TF .

JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (12) :2096-2103

[6] Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].

Belshe, RB ;

Gruber, WC ;

Mendelman, PM ;

Cho, I ;

Reisinger, K ;

Block, SL ;

Wittes, J ;

Iacuzio, D ;

Piedra, P ;

Treanor, J ;

King, J ;

Kotloff, K ;

Bernstein, DI ;

Hayden, FG ;

Zangwill, K ;

Yan, LH ;

Wolff, M .

JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175

[7]

Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1

[8] Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines [J].

Durbin, AP ;

Karron, RA .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :1668-1677

[9] Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease [J].

Feltes, TF ;

Cabalka, AK ;

Meissner, C ;

Piazza, FM ;

Carlin, DA ;

Top, FH ;

Connor, EM ;

Sondheimer, HM .

JOURNAL OF PEDIATRICS, 2003, 143 (04) :532-540

[10] RISK OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION FOR INFANTS FROM LOW-INCOME FAMILIES IN RELATIONSHIP TO AGE, SEX, ETHNIC-GROUP, AND MATERNAL ANTIBODY LEVEL [J].

GLEZEN, WP ;

PAREDES, A ;

ALLISON, JE ;

TABER, LH ;

FRANK, AL .

JOURNAL OF PEDIATRICS, 1981, 98 (05) :708-715

← 1 2 3 4 5 →